Structures by: Maxson T.
Total: 7
ADDTop
C13H17N3O6
Organic & biomolecular chemistry (2010) 8, 22 5053-5055
a=6.837(2)Å b=10.470(5)Å c=18.506(6)Å
α=90.00° β=90.00° γ=90.00°
C8N6,2(C12H28N),2(CNS)
C8N6,2(C12H28N),2(CNS)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 25 8734-8743
a=9.6131(11)Å b=11.5468(13)Å c=17.891(2)Å
α=90° β=90.086(7)° γ=90°
C12H28N,1.5(C6F4O2),CNS
C12H28N,1.5(C6F4O2),CNS
Dalton transactions (Cambridge, England : 2003) (2020) 49, 25 8734-8743
a=10.2809(17)Å b=24.653(4)Å c=9.7480(14)Å
α=90° β=90.110(6)° γ=90°
2(C12H28N),(C6N4),2(CNS)
2(C12H28N),(C6N4),2(CNS)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 25 8734-8743
a=14.7446(7)Å b=14.7446Å c=34.4695(18)Å
α=90° β=90° γ=90°
C6H3N3O6,C12H28N,CNS
C6H3N3O6,C12H28N,CNS
Dalton transactions (Cambridge, England : 2003) (2020) 49, 25 8734-8743
a=9.2223(10)Å b=12.5540(16)Å c=20.447(3)Å
α=90° β=90° γ=90°
(3<i>S</i>,4a<i>S</i>,8a<i>S</i>)-<i>N</i>-<i>tert</i>-Butyl-2-{(<i>S</i>)-2-[(<i>S</i>)-1-(2-chloro-4-nitrobenzoyl)pyrrolidin-2-yl]-2-hydroxyethyl}decahydroisoquinoline-3-carboxamide
C27H39ClN4O5
Acta Crystallographica Section E (2015) 71, 11 1401-1407
a=6.4341(7)Å b=20.280(2)Å c=11.0377(12)Å
α=90° β=105.2480(10)° γ=90°
(3<i>S</i>,4a<i>S</i>,8a<i>S</i>)-<i>N</i>-<i>tert</i>-Butyl-2-[(<i>S</i>)-3-(2-chloro-4-nitrobenzamido)-2-hydroxypropyl]decahydroisoquinoline-3-carboxamide
C24H35ClN4O5
Acta Crystallographica Section E (2015) 71, 11 1401-1407
a=18.8408(7)Å b=20.2263(8)Å c=6.7923(3)Å
α=90° β=90° γ=90°